Chemical contraceptives market in Finland

Earlier Report Observations

The market for chemical contraceptives in Finland experienced a gradual contraction from 1 013 million dollars in 2018 to 865 million dollars in 2023. The most pronounced drop occurred in 2020, when the COVID-19 pandemic disrupted supply chains and distribution, temporarily reducing market availability. In the following years, the market stabilized at a lower level, influenced by persistent global supply chain issues and rising raw material costs, which increased production expenses and affected consumer prices.

Throughout the period, state-owned pharmaceutical companies maintained a significant role in production and export activities, helping to sustain domestic output. Consumer preferences also evolved, with a noted shift towards long-acting reversible contraceptives (LARC) and a growing interest in non-hormonal alternatives, which influenced the product mix available on the market.

The market saw a recovery to 896 million dollars in 2024, supported by the launch of innovative products like tablet-form spermicides offering longer protection and new digital support services introduced by state-owned firms. Regulatory changes, including stricter traceability and safety requirements for packaging implemented in 2022-2023, further shaped the market environment by standardizing product information for consumers.

Production chemical contraceptives in Finland

In value, 2017-2020, M $ US

Finland's chemical contraceptives production declined for the second year in a row. In 2020, output was valued at 901 million US dollars, marking a 9.2% decrease from the previous year. Production peaked in 2018 at 1 005 million US dollars, which also saw the largest annual increase of 11.7%.

Annual dynamics of production in Finland in value, 2017-2020, M $ US

Exports chemical contraceptives from Finland

According to industry reports, Finland did not export any chemical contraceptives from 2017 through 2020.

Imports chemical contraceptives to Finland

Imports in kind, kg

The market displayed volatility during the observed period. Imports reached their lowest point in 2019 at 2 246 kg, with the largest annual decline of 90.4% recorded that year. They then surged dramatically in 2020 to 19 002 kg, a 746.1% increase from 2019. The peak occurred in 2017, showing a 12.1-fold difference compared to the 2019 trough.

Annual dynamics of product's imports to Finland in kind, 2017-2020, kg

From 2017 to 2020, Germany, the Netherlands, and the United States were the top suppliers of chemical contraceptives to Finland by volume. Germany accounted for 37.5% of imports, the Netherlands for 28.1%, and the United States for 17.8%. Together, these three countries made up 83.3% of Finland's total imports in kind.

Structure of product's imports in kind by countries, 2017-2020

World map of product's imports to Finland in kind, 2017-2020

Imports in value, K $ US

After two years of decline, Finland's imports of chemical contraceptives increased in 2020, reaching 6 900 thousand US dollars, a 9.5% year-over-year rise. The lowest value was recorded in 2019 at 6 304 thousand US dollars, which also saw the largest annual drop of 26.0%. Overall, from 2017 to 2020, imports fell by 30.5%, equivalent to an annualized decrease of 11.4%.

Annual dynamics of product's imports to Finland in value, 2017-2020, K $ US

Between 2017 and 2020, Germany, the Netherlands, and France were the leading suppliers of chemical contraceptives to Finland by value. Germany contributed 52.4% of import value, the Netherlands 27.0%, and France 12.6%. Collectively, these three countries represented 92.0% of Finland's total import value.

Structure of product's imports in value by countries, 2017-2020

World map of product's imports to Finland in value, 2017-2020